BIOMAT Database Logo BIOMAT Database Logo

Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV). 2004

Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Department of Pediatrics, College of Physicians and Surgeons, Columbia University, Harlem Hospital Center, New York, New York 10025, USA. lr2043@columbia.edu

Progressive multifocal leukoencephalopathy is an infectious demyelinating brain disease caused by the JC virus that is associated with significant morbidity and mortality in the immunocompromised host. We report a case of progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent patient perinatally infected with human immunodeficiency virus (HIV).

UI MeSH Term Description Entries
D007089 Image Enhancement Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural MICROSCOPY, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level. Image Quality Enhancement,Enhancement, Image,Enhancement, Image Quality,Enhancements, Image,Enhancements, Image Quality,Image Enhancements,Image Quality Enhancements,Quality Enhancement, Image,Quality Enhancements, Image
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.
September 2000, The Journal of infection,
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.
September 1998, The New England journal of medicine,
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy.
April 2001, AIDS (London, England),
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.
November 2001, Mayo Clinic proceedings,
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy.
March 1998, AIDS (London, England),
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy.
February 2000, Journal of neurology,
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus.
January 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy.
September 1998, AIDS (London, England),
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
[Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
August 2000, Rinsho shinkeigaku = Clinical neurology,
Lisa-Gaye Robinson, and Claudia A Chiriboga, and Susan E Champion, and Ivan Ainyette, and Monica DiGrado, and Elaine J Abrams
Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
May 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!